Brief: Nykode Receives U.S. Patent For Neoantigen Selection Method
Nov 4 (Reuters) - Nykode Therapeutics ASA NYKD.OL: NYKODE THERAPEUTICS STRENGTHENS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW U.S. PATENT FOR THE NEOANTIGEN SELECTION METHOD FOR VB10.NEO, NYKODE'S INDIVIDUALIZED NEOANTIGEN THERAPY Source text: ID:nObixbBC7a Further company coverage: NYKD.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026